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Abstract
Background: Three types of telescopic nails are mainly used for intramedullary limb lengthening nowadays. Despite some impor-
tant advantages of this new technology (e.g. controlled distraction rate, not restricted availability, possibility to perform accordion
maneuvers), few articles exist on clinical results and complications after lengthening with the PRECICETM nail (Ellipse, USA).
Objectives: The aim of the current study was to describe and analyze the complications associated with lengthening with the
PRECICETM nail. Are the problems preventable when using the PRECICE, related to the distraction rate control, the lengthening
goals and technique and handling?
Methods: We retrospectively reviewed the charts of 9 patients operated between 2012 and 2013 with a PRECICETM nail for a leg length
discrepancy (LLD). The mean age of the patients was 32 years (range, 17 - 48 years). There were 5 femoral and 4 tibial procedures. The
causes of LLD were posttraumatic (n = 5) and congenital (n = 4). The mean LLD was 36.4± 11.4 mm. The minimum follow-ups were 2
months (average, 5 months; range, 2 - 9 months).
Results: The mean distraction rate was 0.5± 0.1 mm/day. We observed in 7 patients differences in achieving the lengthening goals
(average, 1.6 mm; range, -20.0 - 5.0 mm). Average lengthening was 34.7 ± 10.7 mm. All patients reached normal alignment and
normal joint orientation. An unintentional loss of the achieved length during the consolidation phase was noticed in patients with
delayed bone healing in two cases. In the first case (loss of 20mm distraction) the nail could be redistracted and the goal length was
achieved. In the second case (loss of 10mm distraction) the nail broke shortly after the diagnosis and the nail was exchanged.
Conclusions: We report of loss of achieved length after lengthening with a telescopic nail. Weight bearing before complete con-
solidation of the regenerate might be a risk factor for that. Thorough examination of the limb length and careful evaluation of the
radiographs are required in the follow-up period. The PRECICE nail system requires the same vigilance like the other intramedullary
systems too.
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1. Background
In recent years, the use of fully implantable systems
for limb lengthening helped to overcome many problems
associated with the use of external fixator devices such as
pin tract infections, muscle transfixion and malalignment.
In addition, patient comfort and joint mobility have in-
creased (1-6). On the other hand, the general risk of in-
complete bone regeneration and pseudoarthrosis with the
associated risk of material failure and falling short of the
lengthening goal persists. Secondary surgical procedures
to achieve healing and/or the lengthening goal again put
the advantages of the internal implantation into perspec-
tive (6, 7).
Three types of telescopic nails are mainly used nowa-
days: mechanically activated nails (ISKD, Albizzia), motor-
ized nails (Fitbone) and the new magnetically driven nails
(Phenix, Precice) (3, 4, 8-13). The intramedullary skeletal ki-
netic distractor (ISKD) nail (ISKD; Orthofix Inc., Lewisville,
Texas) was the most commonly used intramedullary dis-
tractor. Due to problems with the control of distraction
rate (e.g. runaway nails and nondistracting nails), the mar-
keting of this nail was temporarily revoked in USA (1, 4, 14-
16). Difficulties and pain with the distraction mechanism
and the risk of distraction stop are important problems re-
ported for the Albizzia nail (DePuy, Villeurbanne, France)
(17, 18).
The Fitbone nail (Wittenstein Intens, Igersheim, Ger-
many) is a motorized system, which is associated with
isolated cases of shortening after the planned distraction
length has been reached and functional impairments as
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well as corrosion problems (2, 6). Moreover, its availability
is limited (restricted number of licenses per country).
The Phenix nail (Phenix Medical, France) achieves
the elongation with electromagnetic field acting between
springs positioned within the nail and magnets acting
from the outside. No movements by the patient are re-
quired to activate it. Indeed, the principle of these mag-
netically driven lengthening systems has been successfully
used for the surgical correction of pediatric scoliosis for
some time (19, 20). Problems handling the magnet and lim-
itations of its use with excessive soft tissue bulk of the limb
have been described with the Phenix nail (6, 21).
The PRECICE nail (Ellipse Tech., Irvine, USA) like the
Phenix nail is based on magnetically controlled distrac-
tors. The PRECICE nail was FDA approved in 2011 and has
been available in USA since then. In Europe, it was first
used in 2012. This nail can be used for limb lengthening
and shortening. This technology has already been used in
spine surgery to correct scolosis (MAGECTM, MAGnetic Ex-
pansion Control) (19).
2. Objectives
Despite some important advantages (e.g. controlled
distraction rate, availability, possibility to perform accor-
dion maneuvers), few articles exist on clinical results and
complications after lengthening with the PRECICETM nail.
The aim of the study was to describe and analyze the com-
plications associated with lengthening with the PRECICE
nail, taking into consideration the control of the distrac-
tion rate, the achievement of the distraction goal, and the
complications and the impact on the outcome.
3. Methods
3.1. Data Extraction
The present study was approved by our local Insti-
tutional Review Board (2164 - 2014). We retrospectively
reviewed the charts of all patients who underwent in-
tramedullary femoral lengthening procedures with the
PRECICE nail at our institution between October 2012 and
December 2013.
3.2. Patient Selection
Nine patients (5 femora, 4 tibiae) with LLD ≥ 20mm
were eligible for inclusion in the study. Mean age at the
time of the procedure was 32 years (range, 17 - 48 years). All
nails were inserted in an antegrade fashion. The LLD was
posttraumatic in 5 cases and congenital in 4 cases. Con-
traindications for the use of intramedullary lengthening
nail included open growth plates, active infection, irreg-
ular or overly narrow medullary cavities, and a femur or
tibia too short for the existing nail sizes. One patient lost
follow-up after one month. As a result, the shortest follow-
up was 2 months after healing, with an average of 6 months
and a range of 2 - 11 months.
The reason for the reduced length was posttraumatic
in 5 cases and congenital in 4 cases. Four patients with
length discrepancies of more than 80mm had staged
lengthening. In three cases with femoral shortening, first
stage lengthening with an ISKD nail had been performed
and it was exchanged with a PRECICE nail for the second
stage. In one patient, the LLD was partially corrected on
the femoral side using an ISKD and the remaining deficit
was subsequently adjusted on the tibia using the PRECICE
nail. Of the 9 patients, one patient had knee arthrodesis
and two patients had ankle arthrodesis. One patient had a
concomitant recurvatum deformity at the distal femur of
8°.
The average diameter of the used nails was 11.3 ± 0.9
mm (10.7 - 12.5) with a length ranging from a minimum of
255 to a maximum of 330 mm. None of our patients was a
smoker.
The follow-up examinations did not follow a previously
defined schedule for this study. All data were acquired sec-
ondarily from the available medical records and X-ray im-
ages. Details regarding LLD, achieved lengthening, time to
bone healing, full weight-bearing and time elapsed since
the nail implantation were documented.
The preoperative planning included LLD measure-
ments and limb alignment assessments based on full-
length radiographs of the lower extremities in stand-
ing position. The film focus distance was 1.5 meters. A
calibrated digital radiography system was used (picture
archiving and communication system [PACS]; Centricity,
General Electric, USA). In addition to that, LLDs were clin-
ically evaluated with blocks of a defined height that were
placed under the foot of the shorter side until a neutral
pelvic tilt was reached and the reliability of the length and
axis measurement was hence improved. Regular digital
measurements of the X-ray images were conducted and in-
cluded the leg length difference, deviation of the mechani-
cal axis and the joint orientation angles. The pre-operative
distraction goal was defined by the leg length difference
measured by means of the X-ray images (22). As recom-
mended by the manufacturer, the nail length was selected
such that 2 to 3 cm of the thicker part of the nail were po-
sitioned at the end of the distraction within the distracted
bone segment (23).
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3.3. Surgery and Aftercare
The surgery was conducted in lateral decubitus posi-
tion for the femur and in supine position for the tibia.
The first step was the implantation of two 5 mm Schanz
screws in the proximal and distal part of the femur or tibia
to maintain control of rotation. Transverse osteotomy in
the shaft was conducted in accordance with the preoper-
ative plans using the multiple drill hole technique. This
was followed by intramedullary reaming 2 mm more than
the nail diameter. The nail was then inserted and locked
proximally and distally. Postoperatively mobilization with
partial weight-bearing of 15 kg using underarm crutches
was permitted following one day of bed rest. The length-
ening phase started between day 5 and 7 after the surgery,
at a distraction rate or index of 1 mm per day for the fe-
mur and 0.5 mm for the tibia. The distraction index was
calculated from the length of the radiographic distraction
gap divided by the time between beginnings to the end
of the distraction (3). After being briefed thoroughly, pa-
tients took the external remote controller (ERC) home with
them. During the distraction phase, all patients were fol-
lowed up weekly and then every 6 weeks during the consol-
idation phase. X-ray images were obtained and the distrac-
tion length was measured according to Kirane et al. during
the distraction phase (24). Distraction problems and insuf-
ficient bone regeneration were particularly captured. Pa-
tients were additionally seen between and after the inter-
vals as needed. The scores according to Karlstrom-Olerud
and according to Paley were recorded as clinical scores (22,
25).
We identified all patients who had complications dur-
ing the distraction and/or consolidation phase. Compli-
cations were classified as minor, moderate or major ac-
cording to Dahl et al. (26). Minor complications neither
had an impact on the outcome nor did they require a pro-
longed intervention. Brief major complications or per-
sistent minor complications were classified as moderate
complications. Major complications were ones that led
to unplanned, additional surgery or to permanent conse-
quential damages. LLDs > 10mm at the end of the proce-
dure was classified as major complications (27). We used
the same definitions formulated earlier to evaluate insuffi-
cient bone regeneration (14, 28).
3.4. Data Analysis
All required statistical analyses were performed us-
ing the SPSS software (IBM SPSS® Statistics 21.0; SPSS Inc.,
Chicago, IL, USA). To analyze the data, descriptive statistics
was also used. Continuous variables are presented as mean
± standard deviation (SD). Since no groups were compared
in this post-marketing surveillance study, no power analy-
sis was conducted. In accordance with the guidelines by
Kirane et al. (24), we calculated the accuracy and the pre-
cision of the measurements relating to the distraction and
elongation by means of standard equations.
4. Results
4.1. Control of the Distraction Rate
The average distraction rate was 0.39 ± 0.88 mm/day
and the average consolidation index 33.45± 10.31 days/cm.
No runaway (unintentional distraction rate > 1.5 mm/day)
or nondistracting nails were recorded. Two cases of short-
ening after achieving the desired length were reported (see
complications).
Knee and ankle ranges of motion (ROM) were not af-
fected. One patient with 8° of recurvatum deformity of the
distal femur was acutely corrected through the lengthen-
ing osteotomy.
4.2. Achievement of the Distraction Goal
The average planned length after the correction was
36.4± 11.4 mm, with a range of 20 to 50 mm and a median
of 35 mm. The average difference between the achieved
length at the end of the correction and the planned length
was -1.18 ± 5.15 mm (range, 12.7 mm shortening to 5.1
mm lengthening). Three patients consequently had over
lengthening compared to the target length, three had still
some shortening and one patient a considerable shorten-
ing with breakage of the nail (see complications). One pa-
tient achieved the planned length exactly and one patient
was lost to follow-up.
The combined arithmetic mean of the achieved total
lenghtening for all patients was 35 mm (range: 21 - 52 mm).
The reliability of the PRECICE was 8/9 nails overall, 4/4 tibial
nails and 4/5 femoral nails. The accuracy of the distraction
was 78.0% ± 10.7% and the precision was 61%.
4.3. Complications
Two patients experienced complications; one moder-
ate and one severe combined with type I regenerate failure
(26, 28). In both cases, the nails recoiled after the end of
distraction resulting in loss of the achieved length.
In the first case (No. 3 in Table 1), the target length
of 50 mm was reached as planned three months after the
surgery, with a distraction index of 0.5 mm/day. As there
was evidence of callus, partial weight-bearing with rapid
increase to full weight-bearing was permitted after the 4th
postoperative month. The loss of the achieved length re-
duction was noticed at the 6th postoperative month and
the nail was redistracted again without any further oper-
ations until full consolidation (Figure 1). The distraction
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Table 1. Patients and Results
Patient No Gender/Age Etiology Bone Included Nail Size,mm Limb Length
Ob-
tained/Projected,
mm
Distraction
Index
(mm/Day)
Follow- Up
(Month)
Failure Details
1 m/17 Congenital femur 10.7×330 52/50 0.7 4 none
2a f/19 Congenital tibia 10.7×305 21/25 0.4 7 none
3b f/46 Congenital tibia 10.7× 305 30/50 0.4 7 Shortening after
reaching the
distraction
length
4 m/19 Trauma tibia 10.7× 330 35/35 0.5 Lost to
follow-up
none
5 f/44 Trauma femur 12.5× 255 33/38 0.5 6 none
6c ,d m/26 Trauma femur 12.5× 265 52/50 0.6 9 Breakage of nail
after nonunion.
Breakage likely
due to fall
7d m/40 Trauma femur 12.5× 255 30/30 0.5 2 none
8d m/31 Trauma femur 10.7× 260 35/30 0.7 3 none
9 f/48 Congenital tibia 10.7× 255 25/20 0.6 2 none
µ 32 - - - 35/36 0.5 5 -
aPrevious lengthening with ISKD in the femur.
bUneventfully second lengthening with the same nail.
cRequired additional operation for nonunion repair, PRECICE replaced by standard intramedullary nail and autologous bone grafting
dPrevious lengthening with ISKD in the same bone
index was again 0.5 mm/day. The achieved length was 47
mm.
The second patient (No. 6 in Table 1) suffered from
90 mm posttraumatic femoral shortening as a result of
femoral shaft fracture. An initial femoral lengthening of 30
mm by means of an ISKD nail was achieved without com-
plications. Once the consolidation had been complete, the
PRECICE was implanted with a planned target lengthening
of 50 mm. The distraction index was 1 mm/day. The length-
ening was complete in three months after the surgery.
Starting from the 4th month, partial weight-bearing was
allowed and unnoticed increasing loss of achieved length
with concurrent type I regenerate failure emerged. The
nail broke at the 10th month after the surgery (Figure 2).
The patient underwent an unplanned surgery with reamed
exchange nailing using cannulated femoral nail (CFN) and
autologous bone grafting.
None of the patients had deep infection. No significant
pain associated with lengthening was reported. One pa-
tient was lost to the follow-up after the surgery, because he
was residing abroad. As a result, we were unable to calcu-
late the distraction and consolidation index (missing val-
ues in Table 1).
4.4. Outcome
Eight patients achieved full weight-bearing after an av-
erage of 12 weeks (6 - 28 weeks).
An average improvement by 3 points was attained in
the score according to Karlstrom and Olerud, from 26
(moderate) before the surgery to 29 (satisfactory) after the
surgery. At the last follow-up, 5 of 8 patients had a good or
satisfactory result, moderate (n = 2) and poor (n = 1). The av-
erage postoperative score according to Paley after the com-
pletion of the distraction and achievement of full weight-
bearing was 86.0± 7.3, corresponding to excellent results
(n = 2) and good outcome (n = 6).
5. Discussion
Preliminary results from North America and Europe
show that the PRECICE nail system allows a reliable and
PRECICE correction of LLDs (24, 29-31). In particular, the
mechanical problems reported with other lengthening
nails such as “runaway” phenomena or nondistracting
nails requiring manipulations under anesthesia or revi-
sion surgery have not been described so far. We would re-
port our results and two serious complications with the
use of PRECICE nail.
Patients were not randomized and only descriptive sta-
tistical analyses were conducted. As this is a case series in-
volving the description of two particular complications,
it is impossible to say whether the rate of complications
was greater or smaller than bone lengthening with con-
ventional methods.
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Figure 1. A-E, A 46-Year Old Woman, Patient No. 3
(A-C), shortening about 20 mm after reaching the distraction length 3 months after the surgery with PRECICE nail; (D-E), redistraction and bone consolidation 12 months later.
One of the obvious advantages of the PRECICE nail is
the externally triggered control of the lengthening mech-
anism and the control of the distraction rate (29, 31). In
accordance with our results, Schiedel et al. reported a dis-
crepancy between the radiologically measured length and
the length shown on the monitor of the external remote
controller (ERC). This phenomenon occurred in 10 of 23
cases and the bone regenerate was on average 10% shorter
than expected. An inadvertent displacement of the ERC
during the lengthening procedure and the performance
of the lengthening in an outpatient setting by the patient
without the presence of the clinician is said to be a possible
reason for this. In addition, the PRECICE system should not
be used in patients with a BMI of > 35, because the thicker
surrounding soft tissue increases the distance from the
ERC to the nail. This may interfere with the nail rotations
through the magnet (31). In our study, the bone regener-
ate was on average 4% shorter than initially planned. Al-
though, these differences were not clinically relevant, we
believe that patient training regarding the appropriate use
of the ERC and regular follow-ups during the lengthening
phase are essential for the success of the procedure.
Two complications graded as serious according to the
classification by Dahl were encountered (26). The com-
plications were likely due to nail-related as well as nail-
unrelated reasons. Patient No. 3 experienced loss of the
achieved lengthening with transition from partial to full
weight bearing. The shortening was 20 mm and we were
able to equalize it again by reactivating the ERC, since the
bone regenerate was still flexible enough to be stretched.
The subsequent healing process was complication free and
the difference to the planned target length was 5 mm.
Patient No. 6 had a posttraumatic LLD of 90 mm. A 2-
stage procedure was performed. In the first stage the fe-
mur was lengthened 40mm without any complications.
At the second stage, the patient developed a partial regen-
erate insufficiency with 10 mm shortening in the consol-
idation phase and breakage of the nail. It is known that
prior surgeries increase the probability of poor bone re-
generation. This can result in delayed bone healing and
Arch Trauma Res. 2016; 5(4):e36273. 5
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Figure 2. 2A-F, A 26-Year-Old Man, Patient No. 6
(A-D), AP radiographs show delayed consolidation and shortening of the femur; (E), Breakage of nail after nonunion 10 months after PRECICE implantation; (F), after removal,
bone graft and CFN with 1 cm LLD.
Figure 3. A, B, Nail Breakage in the Middle of the Nail in the PRECICE Nail in the
Patient Shown in Figure 2
a prolonged consolidation phase (14, 16, 30). In addition,
the weight bearing was likely increased rapidly in this case.
Schiedel et al. reported 2 cases of nail breakage during the
consolidation in their study of 24 patients. They explained
it with increased tension in the nail with the starting con-
solidation of the bone regenerate or accidental shortening
(31).
The PRECICE device was designed to be modular. This
modularity provided a novel way to customize the im-
plant to any approach the surgeon might need. While
this novel feature was a convenience for inventory man-
agement and flexibility, it presented a potential weak point
when stressed. According to the manufacturer, the mod-
ularity was removed in the second generation of the PRE-
CICE to improve the strength of the device by making the
outer tube one complete piece. Any welds on the “motor”
section of the implant were removed.
Another change in the PRECICE II implant was the im-
plementation of a “keeper”. In rare occasions an active pa-
tient could move their leg to cause a loss of distraction in
the nail. This is what likely happened to the second patient
with the shortening. The addition of the “keeper” would
eliminate the possibility that the nail might lose distrac-
tion by unwinding. Baumgart and Thaller described a sim-
ilar problem for the Fitbone nails (6, 8).
The two complication-related acute problems were
treated nonsurgically in case No. 3 and with a renewed sur-
gical intervention in case No. 6. The treatment duration in-
creased significantly in both cases and full weight bearing
was only possible at 28 and 30 weeks, respectively. In both
cases, the planned lengthening goal was not fully reached.
Lascombes et al. (7) are the only authors who include the
therapy duration as an additional criterion in the classifi-
cation of complications. In doing so, the time of full weight
bearing is relevant when bones are lengthened with nail
systems. Accordingly, this concerns grade IIIb complica-
tions.
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Despite the complications, patient satisfaction in
terms of comfort and ease of using the device was gener-
ally positive. We did not record any infections or nerve
damages. Knee and ankle ranges of motion were not af-
fected. Only 1 patient reported worsening of the Karlström-
Olerud score compared to the preoperative score. This was
patient No. 6, who required revision surgery to treat the
complication. Nevertheless, he achieved a favorable Paley
score. From a subjective point of view, patients appeared
to have been satisfied with the treatment.
The accuracy and precision were 78% and 61%, respec-
tively and they were lower in our study compared to other
studies (24, 31). The two complications in a small number
of cases caused these low rates. In contrast, the reliability
was 0.8 (8 of 9 implanted nails), and is hence comparable
with other studies investigating the PRECICE with 0.9 and
the ISKD with 0.8 (5, 31).
The present study has some limitations. First, small
sample size is a universal problem for studies investigat-
ing uncommon procedures, such as intramedullary limb
lengthening. Second, we did not consider long-term out-
comes. Finally, we did not compare this new technology
with other lengthening techniques (e.g. lengthening over
nail, lengthening with other intramedullary distractors).
This study should be considered a preliminary report.
The new generation nail is said to have remedied the
described problems with the PRECICE nail we used. When
ensuring proper instruction of the patients and regular
monitoring of the ratio of measured and indicated length-
ening, the PRECICE nail is a safe and convenient system for
the correction of leg length discrepancies. Irrespective of
the nail, healing delays in existing healed bone regenera-
tion should be expected in connection with renewed cal-
lus distractions. Post-marketing surveillance is very impor-
tant to see if the new technology in PRECICE II Nail is safe
or not and to improve the precision and accuracy of the dis-
traction.
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